• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The disease of 21 century: Development of a novel therapy for ATTR amyloidosis based on the pathogenesis of amyloid formation mechanism

Research Project

Project/Area Number 22K07528
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 52020:Neurology-related
Research InstitutionNagasaki International University

Principal Investigator

安東 由喜雄  長崎国際大学, 薬学部, 教授 (20253742)

Co-Investigator(Kenkyū-buntansha) 田崎 雅義  熊本大学, 大学院生命科学研究部(保), 教授 (50613402)
植田 光晴  熊本大学, 大学院生命科学研究部(医), 教授 (60452885)
松下 博昭  長崎国際大学, 薬学部, 訪問研究員 (60732394)
Project Period (FY) 2022-04-01 – 2025-03-31
Project Status Granted (Fiscal Year 2023)
Budget Amount *help
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2024: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2023: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2022: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Keywordsアミロイドーシス / トランスサイレチン / ATTRwtアミロイドーシス / 老人性全身性アミロイドーシス / amyloid enhancing factor / 病因 / 老化 / 家族性アミロイドポリニューロパチー / ATTRwt アミロイドーシス / ATTRv アミロイドーシス / グラボノイド / グラブリジン / 安定化剤 / ミスフォールディング / ATTR / 治療 / アミロイド促進因子
Outline of Research at the Start

ATTR アミロイドーシスは何故 ageing と共にアミロイド形成が進展するのかは不明である。それまで機能蛋白として挙動していたアミロイド前駆蛋白質が、老化と共にアミロイドを形成し臓器に沈着する「アミロイド形成カスケード」が作動するには可溶性のアミロイド前駆蛋白質をアミロイド形成に向かわせるアミロイド促進因子(AEF)が必要である。本研究では ATTRv とATTRwt アミロイドーシスの 2 疾患に焦点を絞りこの AEFを同定し、in vitro、in vivo 両面で AEF と TTR アミロイドの相互作用をブロックする化合物を同定し、新たな治療薬を開発することを最終目的とする。

Outline of Annual Research Achievements

アミロイドーシスの一型であるATTR アミロイドーシス(家族性アミロイドポリニューロパチー(ATTRv アミロイドーシス:旧 名 FAP)および老人性全身性アミロイドーシス(ATTRwt アミロイドーシス:旧名 SSA)は、臨床症状の進行を緩徐にする疾患修飾薬は開発されてきているが、何故 ageing と共にアミロイド形成が形成され、進展するのか、特定の臓器にアミロイドが沈着するのかなどはほとんど明らかにされていない。これを解き明かすことは 21 世紀の神経難病 (特にproteinopathy)の治療戦略を立てる上で重要な鍵となる。Ageingと共にタンパク質が凝集し、proteinopathyを引き起こす過程と、アミロイドを形成しアミロイドーシスを引き起こす過程には、共通のpathogenesisがあり、key moleculeがあると考える。アミロイドーシスにおいては、それまで機能蛋白として挙動していたアミロイド前駆蛋白質が、老化と共にアミロイドを形成し臓器に沈着する「アミロイド形成カスケー ド」が作動するには可溶性のアミロイド前駆蛋白質をアミロイド形成に向かわせるアミロイド 促進因子(amyloid enhancing factor: AEF)が必要であると考えられている。本研究では ATTRv アミロイドーシスと共に神経症状も合併する ATTRwt アミロイドーシスの 2 疾患に焦点を絞りこの AEF を同定し、in vitro、in vivo 両面で AEF と TTR アミロイドの相互作用をブロックするリーディング化合物を同定し、最終的には、新たな治療薬を開発することを最終目的とする。

Current Status of Research Progress
Current Status of Research Progress

2: Research has progressed on the whole more than it was originally planned.

Reason

amyloid enhancing factor (AEF)の候補として、これまでの研究からpo E、Vitronection、clastarin, β-enolaseなどが候補タンパク質としてクローズアップされた。それぞれのAEF候補タンパク質に対する抗体を購入し、上記のATTRv、SSAの生検、剖検組織で沈着アミロイド中に共存するか免疫組織学的手法を用い検討したところ、これらの候補タンパク質の組織での発現が確認された。 本年度は 我々が生成したリコンビナントTTRwt蛋白質を、試験管内でacidic solution(pH 3.0)でインキュベートするとアミロイド形成を来たすことが判明しているので、この実験系で、これらのAEFをそれぞれ共存させ、アミロイドの形成が増強すかどうかを検証したところ、期待した結果が得られた。

Strategy for Future Research Activity

上記研究結果を基に、さらに質量分析、病理、細胞培養(血管平滑筋細胞)の手法を用いてATTRv およびSSAのアミロイド沈着促進の鍵を握るAEFを決定する。またAEFとTTRアミロイドの相互作用を明らかにする。これらの結果を踏まえて 相互作用をブロックするリーディング化合物を同定することで、新たな治療薬の開発を目指す。
最後に、我々が確立したハイスループットなアミロイド形成阻害剤のスクリーニングシス
テム(Ueda et al., J Biol Chem 2019)を活用し、AEFの効果を阻害する薬剤を探索する。具体的には、既存薬2,000種のライブラリーを用いて、試験管内でTTR81-127およびAEFとインキュベーションさせ、最もアミロイド線維形成を阻害する薬剤を見出す。さらに、阻害後の線維の形態を電子顕微鏡で確認する。

Report

(2 results)
  • 2023 Research-status Report
  • 2022 Research-status Report
  • Research Products

    (42 results)

All 2024 2023 2022 2021

All Journal Article (32 results) (of which Int'l Joint Research: 8 results,  Peer Reviewed: 32 results,  Open Access: 22 results) Presentation (9 results) (of which Int'l Joint Research: 1 results,  Invited: 9 results) Funded Workshop (1 results)

  • [Journal Article] Correlation between a commercial electrophysiological test of sudomotor function and intraepidermal nerve fiber density in hereditary transthyretin2024

    • Author(s)
      Masuda T, Misumi Y, Nomura T, Yamakawa S, Tasaki M, Obayashi K, Ando Y, Ueda M
    • Journal Title

      Muscle Nerve

      Volume: 69 Issue: 1 Pages: 99-102

    • DOI

      10.1002/mus.28005

    • Related Report
      2023 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Characterization of heterozygous ATTR Tyr114Cys amyloidosis-specific induced pluripotent stem cells2024

    • Author(s)
      Ouchi K, Isono K, Ohya Y, Shiraki N, Tasaki M, Inomata Y, Ueda M, Era T, Kume S, Ando Y, Jono H.
    • Journal Title

      Heliyon

      Volume: 10 Issue: 2 Pages: 230-236

    • DOI

      10.1002/ana.26845

    • Related Report
      2023 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Silencing of ocular transthyretin, a gene responsible for hereditary transthyretin amyloidosis, by intravitreal injection of an siRNA conjugate into rabbit eyes2024

    • Author(s)
      Watanabe T, Takihara Y, Jono H, Fujimoto T, Tasaki M, Isoguchi A, Urahashi Y, Shimoda T, Takahashi E, Ando Y, Ueno S, Ueda M, Inoue T.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 694 Issue: 2 Pages: 149397-149397

    • DOI

      10.1111/pin.13395

    • Related Report
      2023 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Disease-Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy2024

    • Author(s)
      Ueda M, Misumi Y, Nomura T, Tasaki M, Yamakawa S, Obayashi K, Yamashita T, Ando Y.
    • Journal Title

      Ann Neurol

      Volume: 95 Pages: 230-236

    • DOI

      10.1016/j.bbrc.2023.149397

    • Related Report
      2023 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Epidemiological study of the subtype frequency of systemic amyloidosis listed in the Annual of the Pathological Autopsy Cases in Japan2024

    • Author(s)
      Yamaguchi A, Tasaki M, Ueda M, Ando Y, Naiki H.
    • Journal Title

      Pathol Int

      Volume: 74 Issue: 2 Pages: 68-76

    • DOI

      10.1016/j.heliyon.2024.e24590

    • Related Report
      2023 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Origin of transthyretin in cerebral amyloid angiopathy2024

    • Author(s)
      Nomura T, Misumi Y, Tasaki M, Obayashi K, Yamashita T, Ando Y, Ueda M
    • Journal Title

      JAMA Neurology

      Volume: 81 Issue: 4 Pages: 421-423

    • DOI

      10.1001/jamaneurol.2023.5762

    • Related Report
      2023 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal2023

    • Author(s)
      Ando Y, Waddington-Cruz M, Sekijima Y, Koike H, Ueda M, Konishi H, Ishii T, Coelho T.
    • Journal Title

      Orphanet J Rare Dis

      Volume: 18 Issue: 15 Pages: 323-323

    • DOI

      10.1001/jama.2023.18688

    • Related Report
      2023 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] RNA interference in late-stage hereditary transthyretin amyloidosis: a clinicopathological study2023

    • Author(s)
      Beck G, Yonenobu Y, Kawai M, Ikenaka K, Sera F, Ozono T, Shimada Y, Yamashita R, Sakata Y, Morii E, Yoshinaga T, Ando Y, Murayama S, Mochizuki H.
    • Journal Title

      J Neurol

      Volume: 270 Issue: 9 Pages: 4544-4548

    • DOI

      10.1007/s00415-023-11754-7

    • Related Report
      2023 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy2023

    • Author(s)
      Teresa C, Wilson M, Noel R, Chi-Chao C, Yesim P, Cavalcante F, Yuh-Cherng G, Jonas W, Long-Sun R, Cristian R, Pedro A, John L, Laura O, Fabio A, Markus W, Isabel C, Shiangtung W, Gustavo B, Michela B, Jersey C, Steven G, Eugene S, Nicholas J, Ahmad M, Morie R, Y Ando, Julian D, Sami K, P James B
    • Journal Title

      JAMA

      Volume: 330 Issue: 1 Pages: 1448-1458

    • DOI

      10.1186/s13023-023-02910-3

    • Related Report
      2023 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Steep increase in the number of transthyretin-positive cardiac biopsy cases in Japan: evidence obtained by the nation-wide pathology consultation for the typing diagnosis of amyloidosis2023

    • Author(s)
      Naiki Hironobu、Yamaguchi Aina、Sekijima Yoshiki、Ueda Mitsuharu、Ohashi Kenichi、Hatakeyama Kinta、Ikeda Yoshihiko、Hoshii Yoshinobu、Shintani-Domoto Yukako、Miyagawa-Hayashino Aya、Tsujikawa Hanako、Endo Jin、Arai Tomio、Ando Yukio
    • Journal Title

      Amyloid

      Volume: 2 Issue: 3 Pages: 1-6

    • DOI

      10.1080/13506129.2023.2180334

    • Related Report
      2023 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Ingestion of Soybean Sprouts Containing a HASPIN Inhibitor Improves Condition in a Mouse Model of Alzheimer's Disease2023

    • Author(s)
      Tanaka H, Matsushita H, Tokuhiro K, Fukunari A, Ando Y
    • Journal Title

      Biology (Basel)

      Volume: 12 Issue: 2 Pages: 320-320

    • DOI

      10.3390/biology12020320

    • Related Report
      2023 Research-status Report 2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Steep increase in the number of transthyretin-positive cardiac biopsy cases in Japan: evidence obtained by the nation-wide pathology consultation for the typing diagnosis of amyloidosis2023

    • Author(s)
      Naiki H, Yamaguchi A, Sekijima Y, Ueda M, Ohashi K, Hatakeyama K, Ikeda Y, Hoshii Y, Shintani-Domoto Y, Miyagawa-Hayashino A, Tsujikawa H, Endo J, Arai T, Ando Y.
    • Journal Title

      Amyloid

      Volume: 30 Issue: 1 Pages: 321-326

    • DOI

      10.1038/s42003-023-04680-x

    • Related Report
      2023 Research-status Report 2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial2023

    • Author(s)
      Quan D, Obici L, Berk JL, Ando Y, Aldinc E, White MT, Adams D.
    • Journal Title

      Amyloid

      Volume: 30 Issue: 1 Pages: 49-58

    • DOI

      10.1080/13506129.2022.2118043

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Effect of phosphatidic acid on antiganglioside antibody reactivity in the isolated facial diplegia variant of Guillain-Barr? syndrome: a case report2023

    • Author(s)
      Nakahara K, Nakane S, Terasaki T, Ando Y.
    • Journal Title

      Acta Neurol Belg

      Volume: 123 Issue: 1 Pages: 231-232

    • DOI

      10.1007/s13760-020-01592-z

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen2023

    • Author(s)
      Coelho T, Waddington Cruz M, Chao CC, Parman Y, Wixner J, Weiler M, Barroso FA, Dasgupta NR, Jung SW, Schneider E, Viney NJ, Dyck PJB, Ando Y, Gillmore JD, Khella S, Gertz MA, Obici L, Berk JL.
    • Journal Title

      Neurol Ther

      Volume: 12 Pages: 267-287

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Gut microbiota of Parkinson's disease in an appendectomy cohort: a preliminary study2023

    • Author(s)
      Nakahara K, Nakane S, Ishii K, Ikeda T, Ando Y.
    • Journal Title

      Sci Rep

      Volume: 13 Issue: 1 Pages: 2210-2210

    • DOI

      10.1038/s41598-023-29219-2

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Treatment response to Tafamidis quantitatively assessed by serial bone scintigraphy in transthyretin amyloid cardiomyopathy2023

    • Author(s)
      Maeda-Ogata S, Tahara N, Tahara A, Bekki M, Honda A, Sugiyama Y, Igata S, Abe T, Sekijima Y, Ueda M, Ando Y, Fukumoto Y.
    • Journal Title

      J Nucl Cardiol

      Volume: 30 Issue: 1 Pages: 403-404

    • DOI

      10.1007/s12350-022-03137-8

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] 特集 映画を観て精神・神経疾患を知る 『アリスのままで』にみる遺伝子診断の重さ2022

    • Author(s)
      Ando Y.
    • Journal Title

      BRAIN and NERVE

      Volume: 74 Issue: 12 Pages: 1331-1334

    • DOI

      10.11477/mf.1416202243

    • ISSN
      1344-8129, 1881-6096
    • Year and Date
      2022-12-01
    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Feasibility Study of Dendrimer-Based TTR-CRISPR pDNA Polyplex for Ocular Amyloidosis <i>in Vitro</i>2022

    • Author(s)
      Inoue M, Muta K, Mohammed AFA, Onodera R, Higashi T, Ouchi K, Ueda M, Ando Y, Arima H, Jono H, Motoyama K.
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 45 Issue: 11 Pages: 1660-1668

    • DOI

      10.1248/bpb.b22-00452

    • ISSN
      0918-6158, 1347-5215
    • Year and Date
      2022-11-01
    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis2022

    • Author(s)
      Ando Y, Adams D, Benson MD, Berk JL, Plant-Bordeneuve V, Coelho T, Conceicao I, Ericzon BG, Obici L, Rapezzi C, Sekijima Y, Ueda M, Palladini G, Merlini Gi
    • Journal Title

      Amyloid

      Volume: 29 Issue: 3 Pages: 143-155

    • DOI

      10.1080/13506129.2022.2052838

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Inhibitory Effect of the HASPIN Inhibitor CHR-6494 on BxPC-3-Luc, A Luciferase-Expressing Pancreatic Cancer Cell Line2022

    • Author(s)
      Tanaka H, Nishida-Fukuda H, Wada M, Tokuhiro K, Matsushita H, Ando Y.
    • Journal Title

      Cell J

      Volume: 24 Pages: 212-214

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Asymptomatic deep venous thrombosis identified on routine screening in patients with hospitalized neurological diseases2022

    • Author(s)
      Nakajima M, Watari M, Ando Y, Ueda M.
    • Journal Title

      J Clin Neurosci

      Volume: 102 Pages: 13-20

    • DOI

      10.1016/j.jocn.2022.06.002

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Imaging Characteristics for Predicting Cognitive Impairment in Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy2022

    • Author(s)
      Taniguchi Akira、Shindo Akihiro、Tabei Ken-ichi、Onodera Osamu、Ando Yukio、Urabe Takao、Kimura Kazumi、Kitagawa Kazuo、Miyamoto Yoshihiro、Takegami Misa、Ihara Masafumi、Mizuta Ikuko、Mizuno Toshiki、Tomimoto Hidekazu
    • Journal Title

      Frontiers in Aging Neuroscience

      Volume: 14 Pages: 01-08

    • DOI

      10.3389/fnagi.2022.876437

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Early transverse tubule involvement in cardiomyocytes in hereditary transthyretin amyloidosis: a possible cause of cardiac events2022

    • Author(s)
      Misumi Y, Ando Y, Ueda M.
    • Journal Title

      Cardiovasc Pathol

      Volume: 61 Pages: 107458-107458

    • DOI

      10.1016/j.carpath.2022.107458

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis2022

    • Author(s)
      Matsushita H, Misumi Y, Masuda T, Okada M, Inoue F, Ueda M, Ando Y.
    • Journal Title

      Pathophysiology

      Volume: 29 Issue: 3 Pages: 333-343

    • DOI

      10.3390/pathophysiology29030025

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation2022

    • Author(s)
      Inoue Y, Tasaki M, Masuda T, Misumi Y, Nomura T, Ando Y, Ueda M.
    • Journal Title

      Cell Mol Life Sci

      Volume: 79 Issue: 8 Pages: 462-462

    • DOI

      10.1007/s00018-022-04493-x

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] SIRT7 Deficiency Protects against Aβ(42)-Induced Apoptosis through the Regulation of NOX4-Derived Reactive Oxygen Species Production in SH-SY5Y Cells2022

    • Author(s)
      Mizutani H, Sato Y, Yamazaki M, Yoshizawa T, Ando Y, Ueda M, Yamagata K.
    • Journal Title

      Int J Mol Sci

      Volume: 23 Issue: 16 Pages: 9027-9027

    • DOI

      10.3390/ijms23169027

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Multifunctional Therapeutic Cyclodextrin-Appended Dendrimer Complex for Treatment of Systemic and Localized Amyloidosis2022

    • Author(s)
      Inoue M, Higashi T, Hayashi Y, Onodera R, Fujisawa K, Taharabaru T, Yokoyama R, Ouchi K, Misumi Y, Ueda M, Inoue Y, Mizuguchi M, Saito T, Saido TC, Ando Y, Arima H, Motoyama K, Jono H.
    • Journal Title

      ACS Appl Mater Interfaces

      Volume: 14 Issue: 36 Pages: 40599-40611

    • DOI

      10.1021/acsami.2c09913

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Macroglossia in rapidly progressive inclusion body myositis2022

    • Author(s)
      Yamasaki Y, Mukaino A, Yamashita S, Takeuchi Y, Tawara N, Yoshida R, Honda Y, Yamashita T, Kakimoto A, Ueyama H, Ando Y.
    • Journal Title

      Neuropathology

      Volume: 0 Issue: 3 Pages: 0-0

    • DOI

      10.1111/neup.12879

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] A novel murine model of autoimmune dysautonomia by α3 nicotinic acetylcholine receptor immunization2022

    • Author(s)
      Yamakawa M, Nakane S, Ihara E, Tawara N, Ikeda H, Igarashi Y, Komohara Y, Takamatsu K, Ikeda T, Tomita Y, Murai S, Ando Y, Mukaino A, Ogawa Y, Ueda M.
    • Journal Title

      Front Neurosci

      Volume: 16 Pages: 1006923-1006923

    • DOI

      10.3389/fnins.2022.1006923

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Carpal tunnel syndrome as an early red-flag sign of ATTRwt amyloidosis2022

    • Author(s)
      Maeda-Ogata S, Tahara N, Bekki M, Tahara A, Sugiyama Y, Honda A, Igata S, Abe T, Ueda M, Ando Y, Hirooka Y, Fukumoto Y.
    • Journal Title

      J Nucl Cardiol

      Volume: 29 Pages: 3562-3563

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging2021

    • Author(s)
      Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.
    • Journal Title

      J Card Fail

      Volume: ー Issue: 7 Pages: e1-e4

    • DOI

      10.1016/j.cardfail.2021.06.012

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Presentation] 21世紀の疾患:アミロイドーシスの病態解明と最新治療、そして未来に向けて2023

    • Author(s)
      安東 由喜雄
    • Organizer
      日本遺伝子細胞治療学会
    • Related Report
      2023 Research-status Report
    • Invited
  • [Presentation] Guidelines and new directions in therapy and monitoring of ATTRv amyloidosis2023

    • Author(s)
      安東 由喜雄
    • Organizer
      日本自律神経学会
    • Related Report
      2023 Research-status Report
    • Invited
  • [Presentation] 21世紀の疾患:遺伝性ATTRアミロイドーシスの病態解明と最新治療、そして未来へむけて2023

    • Author(s)
      安東 由喜雄
    • Organizer
      日本神経治療学会
    • Related Report
      2023 Research-status Report
    • Invited
  • [Presentation] 認知症について2023

    • Author(s)
      安東 由喜雄
    • Organizer
      日本臨床検査医学会
    • Related Report
      2023 Research-status Report
    • Invited
  • [Presentation] ATTRアミロイドーシス診療のこれまでとこれから2023

    • Author(s)
      安東 由喜雄
    • Organizer
      日本アミロイドーシス学会
    • Related Report
      2023 Research-status Report
    • Invited
  • [Presentation] Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis.2022

    • Author(s)
      Ando Y
    • Organizer
      Webinar of International Amyloidosis Society
    • Related Report
      2022 Research-status Report
    • Int'l Joint Research / Invited
  • [Presentation] 21世紀の病気:検査医学のアミロイドーシスの診断・病態解析・治療への貢献2022

    • Author(s)
      安東由喜雄
    • Organizer
      日本臨床検査医学会学術集会
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] FAPといわれた時代からATTRvにいたる研究・診療の変遷2022

    • Author(s)
      安東由喜雄
    • Organizer
      AMED講演会
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] ATTRvアミロイドーシス診断と治療の最前線2022

    • Author(s)
      安東由喜雄
    • Organizer
      Alnylam ATTRアミロイドーシスWeb セミナー関西
    • Related Report
      2022 Research-status Report
    • Invited
  • [Funded Workshop] International Symposium on amyloidosis20242024

    • Related Report
      2023 Research-status Report

URL: 

Published: 2022-04-19   Modified: 2024-12-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi